THE IMPACT OF DONOR AND RECIPIENT HEPATITIS B SURFACE ANTIGEN STATUS ON LIVER DISEASE AND SURVIVAL IN RENAL TRANSPLANT RECIPIENTS

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Transplantation

• Publication date

  1992-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199201000-00025PMID 1733060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural History of Hepatitis B Virus Infection in Renal Transplant Recipients–A Fifteen‐Year Follow‐Up

  2007cited by this paper
• Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology.

  1990cited by this paper
• Chronic hepatitis in kidney allograft recipients.

  1990cited by this paper
• Hepatitis B infection and renal transplantation: the absence of anti-delta antibodies and the possible beneficial effect of silymarin during acute episodes of hepatic dysfunction.

  1989cited by this paper
• Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy.

  1989cited by this paper
• Hepatitis in renal transplant recipients.

  1989cited by this paper
• Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programs

  1988cited by this paper
• Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.

  1988cited by this paper
• Renal transplantation from HBsAg positive donors to HBsAg negative recipients.

  1988cited by this paper
• The influence of hepatitis B infection on the outcome of renal allotransplantation.

  1987cited by this paper
• HEPATITIS B DISEASE IN DIALYSIS AND TRANSPLANT PATIENTS FURTHER EPIDEMIOLOGIC AND SEROLOGIC STUDIES

  1987cited by this paper
• THE IMPACT OF RENAL TRANSPLANTATION ON THE COURSE OF HEPATITIS B LIVER DISEASE

  1985cited by this paper
• Liver disease in recipients of long-functioning renal allografts.

  1985cited by this paper
• Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy.

  1985cited by this paper
• Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus.

  1984cited by this paper
• The transmission of hepatitis B by renal transplantation.

  1983cited by this paper
• Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

  1982cited by this paper
• Impact of hepatitis on renal transplantation.

  1981cited by this paper
• Hepatitis B surface antigenemia in renal transplant recipients. Increased mortality risk.

  1979cited by this paper
• The transplanted kidney as a source of hepatitis B infection.

  1979cited by this paper
• Association of graft survival with host response to hepatitis B infection in patients with kidney transplants.

  1977cited by this paper
• Long-term effect of hbs antigenemia on patient survival after renal transplantation.

  1977cited by this paper
• THE EFFECT OF HEPATITIS B ANTIGENEMIA ON LONG‐TERM SUCCESS AND HEPATIC DISEASE IN RENAL TRANSPLANT RECIPIENTS

  1977cited by this paper
• Reactivation of hepatitis b after transplantation operations.

  1977cited by this paper
• Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.

  1975cited by this paper

• Transmission Risk of Intentional Transplantation of Kidneys From Donors With Active Hepatitis B to Recipients Without Active Hepatitis B: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg− recipients: protocol for a multicentre, prospective, observational study

  2021cites this paper
• Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(−) donors

  2016cites this paper
• Organ Transplantation in HBV-Infected Patients

  2016cites this paper
• Outcomes Among Children Who Received a Kidney Transplant in the United States From a Hepatitis B Core Antibody-Positive Donor, 1995-2010.

  2016cites this paper
• Assessment of Long-Term Outcomes in Hbs Ag-Negative Renal Transplant Recipients Transplanted from Hbs Ag-Positive Donors.

  2015cites this paper
• The Outcomes of Kidney Transplantation in Hepatitis B Surface Antigen (HBsAg)–Negative Recipients Receiving Graft From HBsAg‐Positive Donors: A Retrospective, Propensity Score‐Matched Study

  2014cites this paper
• Kidney transplantation from hepatitis B (HB)-positive donors to HB negative recipients: anti-HB Core immunoglobulin G became positive in all recipients after the transplantation.

  2013cites this paper
• Viral Hepatitis in Solid Organ Transplantation

  2013cites this paper
• Successful kidney transplantation from a hepatitis B surface antigen-positive donor to an antigen-negative recipient using a novel vaccination regimen.

  2013cites this paper
• Hepatitis B virus and renal transplantation.

  2011cites this paper
• Kidney Transplantation from Hepatitis B Surface Antigen Positive Donors into Hepatitis B Surface Antibody Positive Recipients: A Prospective Nonrandomized Controlled Study from a Single Center

  2009cites this paper
• Viral Hepatitis in Solid Organ Transplant Recipients

  2009cites this paper
• Outcomes of kidney grafts refused by one or more centers and subsequently transplanted at a single United Kingdom center.

  2009cites this paper
• HBsAg(+) donor as a kidney transplantation deceased donor.

  2008cites this paper
• Infecciones transmitidas por el donante

  2007cites this paper
• Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantation

  2006cites this paper
• Kidney transplantation from donors with viral B and C hepatitis.

  2006cites this paper
• The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.

  2005cites this paper
• HBsAg Seropositive Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies

  2005cites this paper
• Infections transmitted from donors to recipients following organ transplantation.

  2005cites this paper
• Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.

  2005cites this paper
• Non‐heart–beating donors

  2005cites this paper
• Assessment of donors with sub‐optimal kidney function/structure

  2005cites this paper
• Viral hepatitis guidelines in hemodialysis and transplantation

  2004cites this paper
• Impact of donor infections on outcome of orthotopic liver transplantation

  2003cites this paper
• Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool

  2003cites this paper
• Chronic hepatitis B virus infection in renal transplant recipients.

  2002cites this paper
• Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus)

  2002cites this paper
• Hepatitis B Virus and Renal Transplantation

  2002cites this paper
• Approach to the Management of Allograft Recipients Following the Detection of Hepatitis B Virus in the Prospective Organ Donor

  2001cites this paper
• Criteria for Accepting Donors with Proven or Suspected Infection for Organ Transplantation

  2001cites this paper
• Hepatitis B surface antigen‐positive organ transplantation recipients: Can lamivudine alter their fate?

  2001cites this paper
• Pretransplant evaluation for infections in donors and recipients of solid organs.

  2001cites this paper
• Expanded criteria donors: attempts to increase the renal transplant donor pool.

  2000cites this paper
• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cites this paper
• Organ donor viral screening and its implications in transplantation; an overview.

  2000cites this paper
• Cadaver donor screening for infectious agents in solid organ transplantation.

  2000cites this paper
• SPECIAL SECTION: INFECTIONS IN TRANSPLANTATION AND OTHER IMMUNOCOMPROMISED HOSTS

  2000cites this paper
• Kidney Transplantation in a Child with Posterior Urethral Valve from a Hepatitis B Virus-Carrier Mother

  1999cites this paper
• Long-term outcome of chronic hepatitis B in heart transplant recipients.

  1998cites this paper
• Organ donor screening for infectious diseases: review of practice and implications for transplantation.

  1998cites this paper
• Hepatitis antigenemia and survival after renal transplantation

  1997cites this paper
• Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.

  1997cites this paper
• Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.

  1996cites this paper
• Optimal immunosuppressive regimen for hepatitis B-positive kidney transplant recipients.

  1996cites this paper
• [The problem of viral hepatitis in transplantation medicine].

  1996cites this paper
• An Autopsy Survey Of Hepatitis B In Sydney

  1995cites this paper
• Follow-up of renal allograft recipients from HBsAg positive donors. GCIF.

  1995cites this paper
• Infection in the Organ Transplant Recipient

  1994cites this paper
• Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR.

  1993cites this paper
• Kidney transplantations with HBsAg+ donors.

  1993cites this paper
• Special issues related to transplantation in Hong Kong.

  1992cites this paper